Brain Protection by Methylene Blue and Its Derivative, Azur B, via Activation of the Nrf2/ARE Pathway in Cisplatin-Induced Cognitive Impairment
Open Access
- 30 June 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 815
Abstract
Cisplatin is a cytotoxic chemotherapeutic drug that leads to DNA damage and is used in the treatment of various types of tumors. However, cisplatin has several serious adverse effects, such as deterioration in cognitive ability. The aim of our work was to study neuroprotectors capable of preventing cisplatin-induced neurotoxicity. Methylene blue (MB) and AzurB (AzB) are able to neutralize the neurotoxicity caused by cisplatin by protecting nerve cells as a result of the activation of the Ntf2 signaling pathway. We have shown that cisplatin impairs learning in the Morris water maze. This is due to an increase in the amount of mtDNA damage, a decrease in the expression of most antioxidant genes, the main determinant of the induction of which is the Nrf2/ARE signaling pathway, and genes involved in mitophagy regulation in the cortex. The expression of genes involved in long-term potentiation was suppressed in the hippocampus of cisplatin-injected mice. MB in most cases prevented cisplatin-induced impairment of learning and decrease of gene expression in the cortex. AzB prevented the cisplatin-induced decrease of genes in the hippocampus. Also, cisplatin induced disbalance in the gut microbiome, decreased levels of Actinotalea and Prevotella, and increased levels of Streptococcus and Veillonella. MB and AzB also prevented cisplatin-induced changes in the bacterial composition of the gut microbiome.Keywords
Funding Information
- Scholarship of the President of the Russian Federation (SP-2802.2021.4, 075-03-2020-088, 075001_39782002, 19-44-360011 r_a)
- RF Ministry of Science and Higher Education in the framework of the national project “Science” (SP-2802.2021.4, 075-03-2020-088, 075001_39782002, 19-44-360011 r_a)
- register of State tasks (SP-2802.2021.4, 075-03-2020-088, 075001_39782002, 19-44-360011 r_a)
- Russian Foundation for Basic Research (SP-2802.2021.4, 075-03-2020-088, 075001_39782002, 19-44-360011 r_a)
This publication has 87 references indexed in Scilit:
- Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16Oncology Reports, 2013
- Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotectionProgress in Neurobiology, 2013
- Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome cJournal of Visualized Experiments, 2011
- Turquoise to dark green organs at autopsyVirchows Archiv, 2009
- Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damageOncogene, 2008
- Chapter 20 What are the differences between long-term, short-term, and working memory?2008
- Programmed cell deathsEuropean Journal of Biochemistry, 2004
- Cisplatin-based therapy: a neurological and neuropsychological reviewPsycho-Oncology, 2000
- NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug CisplatinBiochemistry, 1998
- Anti-tumoral and anti-inflammatory effects of biological stainsInflammation Research, 1991